Novartis Tasigna (Nilotinib) Products Liability Lawsuit, Full Case Breakdown Atherosclerosis Claims
The Tasigna (Nilotinib) Products Liability Litigation is a federal Multidistrict Litigation (MDL) in which plaintiffs allege that Novartis Pharmaceuticals Corporation failed to appropriately warn that use of Tasigna may cause severe atherosclerotic injuries, and that Novartis concealed knowledge of Tasigna’s unreasonably dangerous risks from patients, consumers, and the U.S. medical community. As of April 1,…
